Related Experiment Video
Updated: Oct 20, 2025

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
AMPK as a therapeutic target for metabolic syndrome
Gerardo Hernández-Puga1, Kevin David Laguna-Maldonado1, Raúl Gregg-García1
1Universidad Nacional Autónoma de México, Facultad de Medicina, Departamento de Bioquímica. Ciudad de México, México.
Abstract:
The AMP-activated kinase (AMPK) is an important enzyme involved in the regulation of cell metabolism, whose activity is regulated by several mechanisms, mainly the increased concentration of AMP. This enzyme catalyze the phosphorylation of several regulatory proteins implicated in the metabolism of lipids and carbohydrates, upregulating their catabolism. Thus, the AMPK plays an important role in the pathophysiology of some diseases, such as metabolic syndrome and type 2 diabetes mellitus, which have a high prevalence among Mexican population. Because of this, the AMPK has become a relevant target for several drugs used in the management of these pathologies, e.g. metformin and pioglitazone.
Insights
AMP-activated kinase (AMPK) regulates cell metabolism by promoting the breakdown of lipids and carbohydrates. Its role in metabolic diseases makes it a key drug target for conditions like type 2 diabetes.
Area of Science:
- Biochemistry
- Metabolic Regulation
- Pharmacology
Background:
- AMP-activated kinase (AMPK) is a crucial enzyme regulating cellular energy homeostasis.
- AMPK activity is primarily controlled by cellular AMP levels.
- It influences lipid and carbohydrate metabolism by phosphorylating key regulatory proteins.
Purpose of the Study:
- To highlight the significance of AMPK in metabolic regulation.
- To underscore AMPK's role in diseases prevalent in the Mexican population.
- To identify AMPK as a therapeutic target for metabolic disorders.
Main Methods:
- Review of biochemical pathways regulated by AMPK.
- Analysis of AMPK's involvement in pathophysiology of metabolic syndrome and type 2 diabetes.
- Identification of current pharmacological agents targeting AMPK.
Main Results:
- AMPK activation leads to increased catabolism of lipids and carbohydrates.
- AMPK is implicated in the development of metabolic syndrome and type 2 diabetes mellitus.
- Metformin and pioglitazone are examples of AMPK-targeting drugs.
Conclusions:
- AMPK is a central regulator of cellular metabolism.
- Dysregulation of AMPK contributes to prevalent metabolic diseases.
- Targeting AMPK offers a therapeutic strategy for managing metabolic disorders.
More Related Videos
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Regulation of Metabolism
Global Regulatory Systems